Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. STADA Arzneimittel
  6. Summary
    SAZ   DE0007251803

STADA ARZNEIMITTEL

(SAZ)
 SummaryNewsCalendarCompany 
Company
STADA Arzneimittel AG (STADA) is a global pharmaceutical company that focuses on multisource products. Its product portfolio is concentrated on active ingredients, which are free of patent restriction. It focuses on three core business segments: Generics offers drugs in the multisource product category, made from readily available, off-patent active ingredients; Brand-Name Products focuses on multisource products... 
Sector
Pharmaceuticals
Calendar
11/11Earnings Release
More about the company
All news about STADA ARZNEIMITTEL
08/18DGAP-AFR : STADA Arzneimittel AG: Preliminary announcement of the publication of financial..
DJ
06/28Sanofi Divests 16 Brands From European Consumer Healthcare Portfolio
DJ
03/03DGAP-AFR : STADA Arzneimittel AG: Preliminary announcement of the publication of financial..
DJ
2020DIGITAL DOCTORS : Europeans open to apps on prescription
PU
2020STADA ARZNEIMITTEL : Every 2nd European does not know their vaccination status
PU
2020Enzymatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukraine and CIS..
AQ
2020STADA ARZNEIMITTEL AG : Preliminary announcement of the publication of financial reports a..
EQ
2020XBRANE BIOPHARMA PUBL : has completed a directed share issue and thereby raises approximat..
AQ
2020STADA ARZNEIMITTEL : Ex-dividend day for final dividend
FA
2020Bausch + lomb licenses exclusive rights from stada and xbrane to a biosimilar candidate..
AQ
2020Xbrane and STADA partner with Bausch + Lomb for commercialization of Xlucane in the Uni..
AQ
2020STADA ARZNEIMITTEL AG : Preliminary announcement of the publication of financial reports a..
EQ
2020EXCLUSIVE : Germany's Stada buys 15 GSK consumer health brands
RE
2020STADA ARZNEIMITTEL AG : Release of the Home Member State according to Article 5 of the WpH..
EQ
2020STADA ARZNEIMITTEL : to acquire established OTC and food supplement portfolio in the Phili..
PU
More news
News in other languages on STADA ARZNEIMITTEL
08/26Übernahmen treiben Stada an - Corona belastet Arzneiverkäufe
08/18DGAP-AFR : STADA Arzneimittel AG: Vorabbekanntmachung über die Veröffentlichung von Finanz..
08/18STADA ARZNEIMITTEL AG : Vorabbekanntmachung über die Veröffentlichung von Finanzberichten ..
07/27Stada vertreibt rezeptfreie Arzneien von Sanofi
07/27INTERVIEW/Stada schließt Vertriebsvereinbarung mit Sanofi in 20 Ländern
More news
Analyst Recommendations on STADA ARZNEIMITTEL
More recommendations
Managers and Directors
Peter Goldschmidt Chairman-Executive Board
Wolfgang Ollig Chief Financial Officer
GŘnter von Au Chairman-Supervisory Board
Miguel Pagan Fernandez Chief Technical Officer
Jens Steegers Member-Supervisory Board